Really. Not a whole lot more to add about my dog’s just expression until something dramatic happens. We both seek excitement. Surely for her, excitement comes in the form of a treat or a walk. Yet I do not underestimate
July 13, 2017
Two days of gains have helped re-establish the bullish technical picture for tech indices, Nasdaq and Nasdaq 100. While the improvement was welcomed it didn’t come without a price. The Nasdaq broke through declining resistance but also left it itself
The S&P opened above this week’s previous daily opens and briefly oscillated around a narrow point until it steadied and closed the day with a small gain of 0.19%. The index is up 0.93% since last Friday and up 9.34%
Janet Yellen’s testimony before the House committee was what drove markets on Wednesday. The key takeaway from the testimony was that she was moderately more dovish than she was previously. This dovishness led to a rally in stocks and bonds.
The Chart of the Day belongs to SeaSpine Holdings (SPNE). I found the medical technology stock by using Barchart to sort today’s Top Stocks to Own list first by the most frequent number of new highs in the last month, then again by technical buy signals
U.S. stocks were on track for a new record on Thursday as Fed Chair Janet Yellen’s testimony made bulls feel even bolder than they have for most of this year. The strong gains are even more timely, given one economist’s warning that developed countries
The stars — in the form of smart and dumb money futures contract positions — have once again lined up favorably for precious metals. Here are those positions for gold and silver as of Tuesday the 4th. Notice that speculators
Yellen’s speaking again… give it all you’ve got!! Stocks stalled early on (around 1010ET) thanks to inflation comments from Yellen, but that dip was bid back to the highs… then they took a little spill when Fed’s Brainard admitted “asset
To the naked eye, it represents progress. China has still an enormous rural population doing subsistence level farming. As the nation grows economically, such a way of life is an inherent drag, an anchor on aggregate efficiency Chinese officials would
The pharma/biotech sector has picked up this year after being battered by the drug pricing controversy in 2016. The first half has been pretty strong for companies in the space. The NYSE ARCA Pharmaceutical Index has risen almost 9.8% year
